<?xml version="1.0" encoding="UTF-8"?>
<p>Throughout history, plant extracts have been used as remedies for several pathological conditions associated with oxidative stress [
 <xref rid="B19-plants-09-01765" ref-type="bibr">19</xref>,
 <xref rid="B20-plants-09-01765" ref-type="bibr">20</xref>]. The secondary metabolites isolated from the plants of the genus 
 <italic>Lindera</italic> consist of several types of phytochemicals, namely sesquiterpenoids (Linderagalactone E, furanodienone, curzerenone), alkaloids (
 <italic>N</italic>-methyllaurotetanine, (+)-isoboldine), flavonoids (Quercetin-3-O-α-
 <sc>l</sc>-rhamnopyranoside, quercitrin, (−)-epicatechin, Afzelin), phenylpropanoids, butanolides ((2
 <italic>Z</italic>,3
 <italic>S</italic>,4
 <italic>S</italic>)-2-(11-dodecenylidene)-3-hydroxy-4-methyl butanolide and (2
 <italic>E</italic>,3
 <italic>R</italic>,4
 <italic>R</italic>)-2-(11-dodecenylidene)-3-hydroxy-4-methoxy-4-methyl butanolide), lucidones, etc. [
 <xref rid="B2-plants-09-01765" ref-type="bibr">2</xref>]. These secondary metabolites and bioactive compounds isolated from the plants of the 
 <italic>Lindera</italic> genus have been reported to possess various pharmacological activities (e.g., antioxidant, anti-allergic, antimelanogenic, cytoprotective, anti-inflammatory, and antitumour) both in vitro and in vivo (
 <xref rid="plants-09-01765-t001" ref-type="table">Table 1</xref>) [
 <xref rid="B5-plants-09-01765" ref-type="bibr">5</xref>,
 <xref rid="B21-plants-09-01765" ref-type="bibr">21</xref>,
 <xref rid="B22-plants-09-01765" ref-type="bibr">22</xref>,
 <xref rid="B23-plants-09-01765" ref-type="bibr">23</xref>,
 <xref rid="B24-plants-09-01765" ref-type="bibr">24</xref>,
 <xref rid="B25-plants-09-01765" ref-type="bibr">25</xref>].
</p>
